Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

Journal of the American College of Cardiology

Volumn 55, Issue 24, 2010, Pages 2769-2777

  Boogers, Mark J ^a,b   Borleffs, C Jan Willem ^a   Henneman, Maureen M ^a   van Bommel, Rutger J ^a   van Ramshorst, Jan ^a   Boersma, Eric ^c   Dibbets Schneider, Petra ^a   Stokkel, Marcel P ^a   van der Wall, Ernst E ^a   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

123 iodine metaiodobenzylguanidine imaging; implantable cardioverter defibrillator; sympathetic denervation; ventricular arrhythmias

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADREVIEW; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SODIUM IODIDE; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; DEFIBRILLATOR; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART DEATH; HEART DENERVATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL STRESS; PRIORITY JOURNAL; REST; RISK ASSESSMENT; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA, VENTRICULAR;

EID: 73649116237     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.066     Document Type: Article

References (27)

1. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) e247-e346
2. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
3. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
4. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol 51 (2008) e1-e62
5. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
6. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 851 Suppl (1992) I2-I10
7. Podrid P.J., Fuchs T., and Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 822 Suppl (1990) I103-I113
8. Zipes D.P. Sympathetic stimulation and arrhythmias. N Engl J Med 325 (1991) 656-657
9. Mitrani R.D., Klein L.S., Miles W.M., et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 22 (1993) 1344-1353
10. Bax J.J., Kraft O., Buxton A.E., et al. 123-MIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiologic testing. A prospective multicenter pilot study. Circ Cardiovasc Imaging 1 (2009) 131-140
11. Agostini D., Verberne H.J., Burchert W., et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 35 (2008) 535-546
12. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
13. van Ramshorst J., Bax J.J., Beeres S.L., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 301 (2009) 1997-2004
14. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 53 (2009) e1-e90
15. Goldberger J.J., Cain M.E., Hohnloser S.H., et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52 (2008) 1179-1199
16. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
17. de Bakker J.M., van Capelle F.J., Janse M.J., et al. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 88 (1993) 915-926
18. Borger van der Burg A.E., Bax J.J., Boersma E., Pauwels E.K., van der Wall E.E., and Schalij M.J. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 108 (2003) 1954-1959
19. Zipes D.P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82 (1990) 1095-1105
20. Matsunari I., Schricke U., Bengel F.M., et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 101 (2000) 2579-2585
21. Merlet P., Valette H., Dubois-Rande J.L., et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33 (1992) 471-477
22. Merlet P., Benvenuti C., Moyse D., et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40 (1999) 917-923
23. Arora R., Ferrick K.J., Nakata T., et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol 10 (2003) 121-131
24. Nagahara D., Nakata T., Hashimoto A., et al. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med 49 (2008) 225-233
25. Tamaki S., Yamada T., Okuyama Y., et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 53 (2009) 426-435
26. Takeishi Y., Atsumi H., Fujiwara S., Takahashi K., and Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38 (1997) 1085-1089
27. Yamazaki J., Muto H., Kabano T., Yamashina S., Nanjo S., and Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy-clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 141 (2001) 645-652